📑Furnizare diverse medicamente.
Procurement process summary
This process is to purchase Furnizare diverse medicamente.
This contract was awarded by 🇷🇴 Institutul Oncologic Prof. Dr. I. Chiricuta Cluj-Napoca for an amount of RON 2,965,838 to 1 supplier. It was published on 2012-03-24 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇷🇴 Institutul Oncologic Prof. Dr. I. Chiricuta Cluj-Napoca Buying unitnot reported Publication date2012-03-24 Contest statusnot reported DescriptionDiverse medicamente.Awards
This award was granted to SC PHARMA SA by Institutul Oncologic Prof. Dr. I. Chiricuta Cluj-Napoca for an amount of RON 2,965,838. The procurement process was conducted through open for the category of goods. This is award number 23.
This contract has multiple awards. This is award number 23. View other awards for this contract
| Supplier | Amount | Award number |
|---|---|---|
| 🇷🇴 SC PHARMA SA | RON 2,965,838 | 23 |
Market context and opportunities
The execution of this contract allows the entity Institutul Oncologic Prof. Dr. I. Chiricuta Cluj-Napoca to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberRO_ocds-70d2nz-4e7b28ea-e53b-4998-bd2a-cb912a0f98fe-award-23Publication date2012-03-24Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
